Feedback
Settings

Settings

Goto Application

1. WO2016040581 - METHODS OF TREATING SPINAL CORD INJURY

PermaLink
Publication Number WO/2016/040581
Publication Date 17.03.2016
International Application No. PCT/US2015/049360
International Filing Date 10.09.2015
IPC
A61K 38/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
A61K 9/14 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders
A61K 39/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
CPC
A61K 38/191
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
19Cytokines; Lymphokines; Interferons
191Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
A61K 47/60
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
50the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
51the non-active ingredient being a modifying agent
56the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
59obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
60the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Applicants
  • UNIVERSITY OF MIAMI [US]/[US]
  • UNIVERSITY OF SOUTHERN DENMARK [DK]/[DK]
Inventors
  • LAMBERTSEN, Kate, Lykke
  • NOVRUP, Hans
  • BETHEA, John, R.
  • BRACCHI-RICARD, Valerie
Agents
  • NIELSEN, Vivien, Chen
Priority Data
62/048,71510.09.2014US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) METHODS OF TREATING SPINAL CORD INJURY
(FR) MÉTHODES DE TRAITEMENT D'UNE LÉSION DE LA MOELLE ÉPINIÈRE
Abstract
(EN) The present disclosure is directed to a method of treating spinal cord injury and/or symptoms associated with spinal cord by administration to a subject in need thereof a dominant negative TNF-α polypeptide that inhibits the activity of soluble TNF-α but not transmembrane TNF-α.
(FR) La présente invention concerne une méthode de traitement d'une lésion de la moelle épinière et/ou de symptômes associés à la moelle épinière par administration, à un sujet qui en a besoin, d'un polypeptide TNF-α négatif dominant qui inhibe l'activité de TNF-α soluble mais pas celle d'un TNF-α transmembranaire.
Latest bibliographic data on file with the International Bureau
# -